GlaxoSmithKline (GSK) stock forecast for 2024

The forecast has been updated: January 26, 2022 14:10


GlaxoSmithKline stock price online today

Analyst Target Price

48.38

Dividend Date

13.01.2022

Ex Dividend Date

18.11.2021

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell GlaxoSmithKline stock stock today? What is the projected target price level for 2024? How much will it cost in 2024? GlaxoSmithKline stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2024.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $48.38 target price for GlaxoSmithKline stock stock.

Today 200 Day Moving Average is the support level (40.55 $).

50 Day Moving Average is the support level (43.29 $).




GSK Forecast for 2024

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 49.46 48.85 50.68 3.62 %
Feb 49.79 48.65 50.86 4.35 %
Mar 49.56 48.44 50.60 4.28 %
Apr 50.22 49.37 51.78 4.65 %
May 48.53 47.83 49.40 3.18 %
Jun 48.97 47.88 50.40 5.00 %
Jul 49.06 48.62 50.02 2.79 %
Aug 49.77 48.45 50.86 4.73 %
Sep 50.72 49.93 52.07 4.10 %
Oct 50.33 49.60 51.68 4.03 %
Nov 52.23 50.97 53.31 4.39 %
Dec 53.09 52.67 54.68 3.67 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of GlaxoSmithKline stock.


GlaxoSmithKline overview

GlaxoSmithKline Address

980 GREAT WEST ROAD, BRENTFORD MIDDLESEX, GB

Market Capitalization

111 630 475 000 $

EBITDA

10 230 000 000

PE Ratio

19.19

PEG Ratio

3.662

Dividend Per Share

0.8

Dividend Yield

0.0495

EPS

2.312

Quarterly Earnings Growth YOY

-0.065

Quarterly Revenue Growth YOY

0.05

Trailing PE

19.19

Forward PE

14.1

EV To Revenue

4.095

EV To EBITDA

12.36

52 Week High

46.86

52 Week Low

32.26

50 Day Moving Average

43.29

200 Day Moving Average

40.55

Shares Outstanding

2515900000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

GlaxoSmithKline stock forecast for this year


GlaxoSmithKline stock forecast for Jan 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 49.46. Positive monthly dynamics of the instrument is expected with 3.616% volatility is expected.

Pessimistic forecast: 48.85

Optimistic: 50.68


GlaxoSmithKline stock forecast for Feb 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 49.79. Positive monthly dynamics of the instrument is expected with 4.353% volatility is expected.

Pessimistic forecast: 48.65

Optimistic: 50.86


GlaxoSmithKline stock forecast for Mar 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 49.56. Negative monthly dynamics of the instrument is expected with 4.278% volatility is expected.

Pessimistic forecast: 48.44

Optimistic: 50.60


GlaxoSmithKline stock forecast for Apr 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 50.22. Positive monthly dynamics of the instrument is expected with 4.652% volatility is expected.

Pessimistic forecast: 49.37

Optimistic: 51.78


GlaxoSmithKline stock forecast for May 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 48.53. Negative monthly dynamics of the instrument is expected with 3.180% volatility is expected.

Pessimistic forecast: 47.83

Optimistic: 49.40


GlaxoSmithKline stock forecast for Jun 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 48.97. Positive monthly dynamics of the instrument is expected with 5.002% volatility is expected.

Pessimistic forecast: 47.88

Optimistic: 50.40


GlaxoSmithKline stock forecast for Jul 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 49.06. Positive monthly dynamics of the instrument is expected with 2.793% volatility is expected.

Pessimistic forecast: 48.62

Optimistic: 50.02


GlaxoSmithKline stock forecast for Aug 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 49.77. Positive monthly dynamics of the instrument is expected with 4.733% volatility is expected.

Pessimistic forecast: 48.45

Optimistic: 50.86


GlaxoSmithKline stock forecast for Sep 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 50.72. Positive monthly dynamics of the instrument is expected with 4.103% volatility is expected.

Pessimistic forecast: 49.93

Optimistic: 52.07


GlaxoSmithKline stock forecast for Oct 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 50.33. Negative monthly dynamics of the instrument is expected with 4.026% volatility is expected.

Pessimistic forecast: 49.60

Optimistic: 51.68


GlaxoSmithKline stock forecast for Nov 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 52.23. Positive monthly dynamics of the instrument is expected with 4.394% volatility is expected.

Pessimistic forecast: 50.97

Optimistic: 53.31


GlaxoSmithKline stock forecast for Dec 2024.
Estimated Average Forecasted GlaxoSmithKline Price: 53.09. Positive monthly dynamics of the instrument is expected with 3.673% volatility is expected.

Pessimistic forecast: 52.67

Optimistic: 54.68



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 123.82 (24.01.2022) -1.60 %
AbbVie Inc.
ABBV 131.98 (21.01.2022) -0.79 %
Aeterna Zentaris Inc.
AEZS 0.3556 (25.01.2022) 3.55 %
Allakos Inc.
ALLK 6.53 (25.01.2022) -4.11 %
Allogene Therapeutics, Inc.
ALLO 11.36 (25.01.2022) 0.18 %
Amgen Inc.
AMGN 225.04 (25.01.2022) -0.46 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 15.1 (25.01.2022) 3.00 %
Aurora Cannabis Inc.
ACB 4.21 (25.01.2022) -2.55 %
Becton Dickinson and Company
BDX 264.63 (21.01.2022) 0.25 %
Biogen Inc.
BIIB 222.31 (25.01.2022) -1.06 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 110.08 (21.01.2022) -5.10 %
BioNTech SE
BNTX 150.98 (24.01.2022) 2.36 %
bluebird bio, Inc.
BLUE 7.76 (25.01.2022) 0.65 %
Boston Scientific Corp.
BSX 44.86 (14.01.2022) 0.65 %
Bristol-Myers Squibb Company
BMY 62.46 (25.01.2022) -0.24 %
Canopy Growth Corp.
CGC 7.36 (25.01.2022) -0.54 %
Castle Biosciences, Inc.
CSTL 34.97 (25.01.2022) -1.33 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 239.46 (25.01.2022) -0.40 %
Emergent BioSolutions Inc.
EBS 46.97 (21.01.2022) 0.97 %
Exelixis, Inc.
EXEL 18.21 (25.01.2022) -1.67 %
G1 Therapeutics, Inc.
GTHX 9.6 (25.01.2022) 6.90 %
Gilead Sciences, Inc.
GILD 68.84 (25.01.2022) 0.39 %
GlaxoSmithKline plc
GSK 44.37 (25.01.2022) -0.02 %
GoodRx Holdings, Inc.
GDRX 23.95 (25.01.2022) -1.16 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 74.15 (25.01.2022) -1.58 %
Inovio Pharmaceuticals, Inc.
INO 4.04 (25.01.2022) 3.06 %
Johnson & Johnson
JNJ 162.97 (24.01.2022) -1.15 %
Medtronic plc.
MDT 104.17 (25.01.2022) -0.04 %
Merck & Co., Inc.
MRK 79.46 (25.01.2022) 0.80 %
Moderna, Inc.
MRNA 152.54 (25.01.2022) -3.03 %
Novartis AG
NVS 84.54 (25.01.2022) -0.69 %
Novavax, Inc.
NVAX 77.21 (25.01.2022) -2.84 %
ObsEva SA
OBSV 1.48 (25.01.2022) -1.33 %
OrganiGram Holdings Inc.
OGI 1.4 (25.01.2022) -4.11 %
Pfizer Inc.
PFE 52.54 (25.01.2022) 1.94 %
Regeneron Pharmaceuticals, Inc.
REGN 603.19 (25.01.2022) -2.94 %
Sanofi
SNY 51.4 (25.01.2022) 1.10 %
Schrodinger, Inc.
SDGR 27.59 (25.01.2022) -1.36 %
Senseonics Holdings, Inc.
SENS 2.32 (25.01.2022) -2.52 %
Sorrento Therapeutics, Inc.
SRNE 3.51 (25.01.2022) -0.71 %
Stryker Corp.
SYK 249.27 (25.01.2022) -1.05 %
Sundial Growers Inc.
SNDL 0.4764 (25.01.2022) 3.57 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.46 (24.01.2022) -0.59 %
Thermo Fisher Scientific Inc.
TMO 567.75 (25.01.2022) -1.40 %
Tilray, Inc.
TLRY 5.72 (25.01.2022) -2.05 %
UnitedHealth Group, Inc.
UNH 462.27 (24.01.2022) 0.24 %
Veeva Systems Inc.
VEEV 221.32 (25.01.2022) -2.66 %
Zomedica Corp.
ZOM 0.29 (25.01.2022) -3.33 %
Zynerba Pharmaceuticals, Inc.
ZYNE 2.5 (24.01.2022) 5.49 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.